Aurobindo Pharma USA launches new generic tablets
EAST WINDSOR, N.J.— Aurobindo Pharma USA has launched emtricitabine/tenofovir disoproxil fumarate tablets 200mg/300mg, an AB-rated generic equivalent to the reference listed drug Truvada Tablets of Gilead. The tablets hav an estimated market size of $2.2B USD for the twelve months ending January 2021, as per IQVIA.